You are here: Industry Insights > CMA

News List

Blenrep granted CMA for relapsed or refractory multiple myeloma europeanpharmaceuticalreview
August 31, 2020
The European Commission granted the conditional marketing authorisation (CMA) based on data from a trial in which Blenrep achieved an overall response rate of 32 percent.
CMA levies fines of £2.3m in pharma probe pharmatimes
July 10, 2020
The UK's Competition and Markets Authority (CMA) has now formally concluded that three pharmaceutical companies - Aspen, Tiofarma, and Amilco - took part in an illegal arrangement that inflated the price of life-saving medicine fludrocortisone.
CMA imposes £1.2m fines for price-fixing in private eye care pharmatimes
July 01, 2020
Spire Healthcare and Spire Healthcare Group (Spire) has admitted that one of its hospitals 'instigated and facilitated' an illegal arrangement with seven consultant ophthalmologists to fix fees for private eye consultations.
UK CMA disqualifies pharma company director after breaking competition law europeanpharmaceuticalreview
June 16, 2020
A pharmaceutical company director is now banned from holding a director role at any UK company for the next five years after making illegal arrangements.
EMA recieves CMA application for remdesivir as a COVID-19 treatment europeanpharmaceuticalreview
June 10, 2020
The European Medicines Agency (EMA) said its assessment of the conditional marketing authorisation (CMA) application will be performed under a reduced timeframe, with a decision potentially delivered in weeks.
CMA launches COVID-19 taskforce to combat drug price hikes europeanpharmaceuticalreview
March 25, 2020
In the UK, the CMA has announced it will establish a taskforce to handle businesses that exploit the COVID-19 outbreak and inflate drug prices.
CMA levels over £3.4m in fines for competition law breaches europeanpharmaceuticalreview
March 06, 2020
The UK’s Competition and Markets Authority (CMA) has fined four companies in because of anti-competitive practices in the supply of nortriptyline.
Two drug firms admit to colluding to keep prices up europeanpharmaceuticalreview
September 25, 2019
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
Drug supplier Aspen to pay NHS £8m after competition probe europeanpharmaceuticalreview
August 16, 2019
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
Four pharmaceutical companies accused of illegal anti-competitive conduct europeanpharmaceuticalreview
June 21, 2019
The CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.

Previous page 1 2 3 Next page